Effects of scatter correction on regional distribution of cerebral blood flow using I-123-IMP and SPECT

Annals of Nuclear Medicine

Volumn 13, Issue 5, 1999, Pages 331-336

  Ito, Hiroshi ^a   Iida, Hidehiro ^b   Kinoshita, Toshibumi ^b   Hatazawa, Jun ^b   Okudera, Toshio ^b   Uemura, Kazuo ^b  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b NONE

Author keywords

Anatomic standardization; I 123 IMP; Scatter correction; SPECT

Indexed keywords

IOFETAMINE I 123; WATER O 15;

ADULT; ANALYTICAL ERROR; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION SCATTERING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032756607     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164872     Document Type: Article

References (32)

1. Winchell HS, Baldwin RM, Lin TH. Development of I-123-labeled amines for brain studies: Localization of I-123 iodophenylalkyl amines in rat brain. J Nucl Med 21: 940-946, 1980.
2. Ito H, Iida H, Bloomfield PM, Murakami M, Inugami A, Kanno I, et al. Rapid calculation of regional cerebral blood flow and distribution volume using iodine-123-iodoamphetamine and dynamic SPECT. J Nucl Med 36: 531-536, 1995.
3. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 35: 2019-2030, 1994.
4. Ito H, Koyama M, Goto R, Kawashima R, Ono S, Atsumi H, et al. Cerebral blood flow measurement with iodine-123-IMP SPECT, calibrated standard input function and venous blood sampling. J Nucl Med 36: 2339-2342, 1995.
5. 123I-IMP brain SPECT: A comparison study with table look-up method and microsphere model method. Ann Nucl Med 9: 185-190, 1995.
6. Iida H, Narita Y, Kado H, Kashikura A, Sugawara S, Shoji Y, et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med 39: 181-189, 1998.
7. Axelsson B, Msaki P, Israelsson A. Subtraction of Compton-scattered photons in single-photon emission computerized tomography. J Nucl Med 25: 490-494, 1984.
8. Ogawa K, Harata Y, Ichihara T, Kubo A, Hashimoto S. A practical method for position-dependent Compton-scatter correction in single photon emission CT. IEEE Trans Med Imag 10: 408-412, 1991.
9. Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med 34: 2216-2221, 1993.
10. Ogawa K, Ichihara T, Kubo A. Accurate scatter correction in single photon emission CT. Ann Nucl Med 7: 145-150, 1994.
11. Meikle SR. Hutton BF, Bailey DL. A transmission-dependent method for scatter correction in SPECT. J Nucl Med 35: 360-367, 1994.
12. Ljungberg M, King MA, Hademenos GJ, Strand SE. Comparison of four scatter correction methods using Monte Carlo simulated source distributions. J Nucl Med 35: 143-151, 1994.
13. Buvat I, Rodriguez-Villafuerte M, Todd-Pokropek A, Benali H, Di Paola R. Comparative assessment of nine scatter correction methods based on spectral analysis using Monte Carlo simulations. J Nucl Med 36: 1476-1488, 1995.
14. Narita Y, Eberl S, Iida H, Hutton BF, Braun M, Nakamura T, et al. Monte Carlo and experimental evaluation of accuracy and noise properties of two scatter correction methods for SPECT. Phys Med Biol 41: 2481-2496, 1996.
15. Fox PT, Mintun MA, Reiman EM, Raichle ME. Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab 8: 642-653, 1988.
16. Ito H, Kawashima R, Awata S, Ono S, Sato K, Goto R, et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med 37: 410-414, 1996.
17. Minoshima S, Berger KL, Lee KS, Mintun MA. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 33: 1579-1585, 1992.
18. Minoshima S, Koeppe RA, Mintun MA, Berger KL, Taylor SF, Frey KA, et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med 34: 322-329, 1993.
19. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: Linear scaling and nonlinear warping of functional brain images. J Nucl Med 35: 1528-1537, 1994.
20. Minoshima S, Koeppe RA, Frey KA, Ishihara M, Kuhl DE. Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med 35: 949-954, 1994.
21. Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 38: 797-802, 1997.
22. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imag MI-13: 601-609, 1994.
23. Iida H, Miura S, Kanno I, Ogawa T, Uemura K. A new PET camera for noninvasive quantitation of physiological functional parametric images: Headtome-V-dual. In: Myers R, Cunningham Y, Bailey D, Jones T, eds. Quantification of Brain Function Using PET. San Diego: Academic Press, pp. 57-61, 1996.
24. 15O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 78: 104-115, 1988.
25. Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 33: 1669-1677, 1992.
26. 15O. II. Implementation and validation. J Nucl Med 24: 790-798, 1983.
27. 15O autoradiographic method and positron emission tomography. J Cereb Blood Flow Metab 7: 143-153, 1987.
28. Stodilka RZ, Kemp BJ, Prato FS, Nicholson RL. Importance of bone attenuation in brain SPECT quantification. J Nucl Med 39: 190-197, 1998.
29. Law SK. Thickness and resistivity variations over the upper surface of the human skull. Brain Topogr 6: 99-109, 1993.
30. Waldemar G, Christiansen P, Larsson HB, Hogh P, Laursen H, Lassen NA, et al. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: Morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 51: 1458-1465, 1994.
31. Ohnishi T, Hoshi H, Nagamachi S, Jinnouchi S, Flores LG II, Futami S, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatrie diseases. J Nucl Med 36: 1163-1169, 1995.
32. Lehtovirta M, Soininen H, Laakso MP, Partanen K, Helisalmi S, Mannermaa A, et al. SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E epsilon 4 allele. J Neurol Neurosurg Psychiatry 60: 644-649, 1996.